Trial Profile
An Open-Label Study of the Effects of Desloratadine (Aerius.) Treatment on the Quality of Life of Patients With Chronic Idiopathic Urticaria
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 18 Feb 2022
Price :
$35
*
At a glance
- Drugs Desloratadine (Primary)
- Indications Urticaria
- Focus Therapeutic Use
- Sponsors Organon
- 30 Apr 2014 New trial record